The Scientist

» FDA and immunology

Most Recent

image: Smallpox Kerfuffle Reveals Biosecurity Problems

Smallpox Kerfuffle Reveals Biosecurity Problems

By | July 12, 2017

A review of a 2014 incident in which mystery vials of smallpox were found at the NIH reveals security weaknesses, but also concludes the response was appropriate. 

1 Comment

image: T Cells That Drive Toxic Shock in Mice Identified

T Cells That Drive Toxic Shock in Mice Identified

By | June 20, 2017

Overzealous activity by mucosa-associated invariant T (MAIT) cells in response to bacterial toxins can lead to illness instead of stopping it.

0 Comments

Research shows that human immunity develops much earlier than previously thought, but functions differently in adults.

0 Comments

image: Pinpointing the Culprit

Pinpointing the Culprit

By | June 1, 2017

Identifying immune cell subsets with CyTOF

0 Comments

image: Self-Experimentation Led to the Discovery of IgE

Self-Experimentation Led to the Discovery of IgE

By | June 1, 2017

In the 1960s, immunologists took matters into their own hands—and under their own skin—to characterize an immunoglobulin involved in allergies.

0 Comments

image: Infographic: A Body Without Food

Infographic: A Body Without Food

By | June 1, 2017

Mounting evidence suggests that intermittent fasting causes significant changes to various organs and tissue types.

0 Comments

image: Infographic: Immune Irritation in the Gut

Infographic: Immune Irritation in the Gut

By | June 1, 2017

A look at how gluten affects patients with celiac disease

0 Comments

image: Opinion: Token Pharmacovigilance

Opinion: Token Pharmacovigilance

By | May 23, 2017

A US government website for collecting reports of side effects associated with vaccines is broken. Why has no one noticed?

4 Comments

Four products have already qualified for the regenerative medicine advanced therapy (RMAT) designation that provides extra interactions with the agency, and sooner.

0 Comments

image: Second-Ever ALS Drug Approved

Second-Ever ALS Drug Approved

By | May 8, 2017

Amyotrophic lateral sclerosis patients in the U.S. now have an option besides riluzole, which was approved by the FDA more than two decades ago and only extends life by two or three months.

1 Comment

Popular Now

  1. How Animals and Plants Weather Hurricanes
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech